Cerenome, Inc. (CNSY) stock
CNSYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/3070% below fair value
$0.63−0.07 (-10.29%)
Close on Nov 20, 2026Market cap $4.78MP/E –Yield –
Cerenome net income
Net income is the profit left for shareholders after every expense, interest and tax.
Cerenome's net income for the twelve months ending Jun 30, 2026 was -$26.09M. For fiscal 2025 it was -$22.39M. The highest annual figure on record is -$8.24M in fiscal 2020.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$22.39M | – |
| FY2024 | Dec 31, 2024 | -$12.98M | – |
| FY2023 | Dec 31, 2023 | -$13.32M | – |
| FY2022 | Dec 31, 2022 | -$20.28M | – |
| FY2021 | Dec 31, 2021 | -$13.40M | – |
| FY2020 | Dec 31, 2020 | -$8.24M | – |
| FY2019 | Dec 31, 2019 | -$10.89M | – |
| FY2018 | Dec 31, 2018 | -$12.63M | – |
| FY2017 | Dec 31, 2017 | -$22.69M | – |
| FY2016 | Dec 31, 2016 | -$22.05M | – |
| FY2015 | Dec 31, 2015 | -$18.74M | – |
| FY2014 | Dec 31, 2014 | -$37.37M | – |
| FY2013 | Dec 31, 2013 | -$26.18M | – |
| FY2012 | Dec 31, 2012 | -$32.28M | – |
| FY2011 | Dec 31, 2011 | -$32.45M | – |
| FY2010 | Dec 31, 2010 | -$27.49M | – |
| FY2009 | Dec 31, 2009 | -$23.22M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$9.01M | -274.8% |
| Q1 FY2026 | Mar 31, 2026 | -$6.95M | – |
| Q4 FY2025 | Dec 31, 2025 | -$5.71M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.42M | – |
| Q2 FY2025 | Jun 30, 2025 | $5.15M | – |
| Q1 FY2025 | Mar 31, 2025 | -$17.40M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.90M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.87M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.94M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.26M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.81M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.22M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.48M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.81M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.66M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.22M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.28M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.12M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.16M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.72M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.80M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.72M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.59M | -505.8% |
| Q3 FY2020 | Sep 30, 2020 | -$1.73M | -428.5% |
| Q2 FY2020 | Jun 30, 2020 | -$1.84M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.09M | – |
| Q4 FY2019 | Dec 31, 2019 | $884.00K | – |
| Q3 FY2019 | Sep 30, 2019 | $526.00K | – |
| Q2 FY2019 | Jun 30, 2019 | -$9.15M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.15M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.24M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.41M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.29M | – |
| Q3 FY2017 | Sep 30, 2017 | -$4.81M | – |
| Q2 FY2017 | Jun 30, 2017 | -$6.05M | – |
| Q1 FY2017 | Mar 31, 2017 | -$7.54M | – |
| Q4 FY2016 | Dec 31, 2016 | -$4.92M | – |
| Q3 FY2016 | Sep 30, 2016 | -$5.38M | – |
| Q2 FY2016 | Jun 30, 2016 | -$6.41M | – |
See a number that looks wrong?